Global and China Intravenous Immunoglobulin (IVIg) Market Insights, Forecast to 2027

Global and China Intravenous Immunoglobulin (IVIg) Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Intravenous Immunoglobulin (IVIg) Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Market by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravenous Immunoglobulin (IVIg) Market Size, Estimates and Forecasts
2.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2016-2027
2.1.2 Global Intravenous Immunoglobulin (IVIg) Sales 2016-2027
2.2 Global Intravenous Immunoglobulin (IVIg), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Intravenous Immunoglobulin (IVIg) Historical Market Size by Region (2016-2021)
2.3.1 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2022-2027)
2.4.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2022-2027)
3 Global Intravenous Immunoglobulin (IVIg) Competitor Landscape by Players
3.1 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Sales
3.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2021)
3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Revenue
3.2.1 Key Intravenous Immunoglobulin (IVIg) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2021)
3.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Intravenous Immunoglobulin (IVIg) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Intravenous Immunoglobulin (IVIg) Revenue in 2020
3.2.6 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Intravenous Immunoglobulin (IVIg) Price by Manufacturers
3.4 Global Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution, Product Types
3.4.1 Intravenous Immunoglobulin (IVIg) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
3.4.3 Date of International Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Type (2016-2021)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2021)
4.1.3 Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Intravenous Immunoglobulin (IVIg) Market Size Forecast by Type (2022-2027)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2022-2027)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2022-2027)
4.2.3 Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Application (2016-2021)
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2021)
5.1.3 Intravenous Immunoglobulin (IVIg) Price by Application (2016-2021)
5.2 Intravenous Immunoglobulin (IVIg) Market Size Forecast by Application (2022-2027)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2022-2027)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2022-2027)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2016-2027
6.1.1 China Intravenous Immunoglobulin (IVIg) Sales YoY Growth 2016-2027
6.1.2 China Intravenous Immunoglobulin (IVIg) Revenue YoY Growth 2016-2027
6.1.3 China Intravenous Immunoglobulin (IVIg) Market Share in Global Market 2016-2027
6.2 China Intravenous Immunoglobulin (IVIg) Market Size by Players (International and Local Players)
6.2.1 China Top Intravenous Immunoglobulin (IVIg) Players by Sales (2016-2021)
6.2.2 China Top Intravenous Immunoglobulin (IVIg) Players by Revenue (2016-2021)
6.3 China Intravenous Immunoglobulin (IVIg) Historic Market Review by Type (2016-2021)
6.3.1 China Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
6.3.2 China Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2021)
6.3.3 China Intravenous Immunoglobulin (IVIg) Price by Type (2016-2021)
6.4 China Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2022-2027)
6.4.2 China Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2022-2027)
6.4.3 China Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2022-2027)
6.5 China Intravenous Immunoglobulin (IVIg) Historic Market Review by Application (2016-2021)
6.5.1 China Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
6.5.2 China Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2016-2021)
6.5.3 China Intravenous Immunoglobulin (IVIg) Price by Application (2016-2021)
6.6 China Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2022-2027)
6.6.2 China Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2022-2027)
6.6.3 China Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2022-2027)
7 North America
7.1 North America Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2016-2027
7.2 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
7.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021)
7.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Region
8.2.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021)
8.2.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2016-2027
9.2 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
9.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021)
9.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2016-2027
10.2 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
10.2.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021)
10.2.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
11.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Description and Business Overview
12.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Baxter Intravenous Immunoglobulin (IVIg) Products Offered
12.1.5 Baxter Recent Development
12.2 Grifols
12.2.1 Grifols Corporation Information
12.2.2 Grifols Description and Business Overview
12.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Grifols Intravenous Immunoglobulin (IVIg) Products Offered
12.2.5 Grifols Recent Development
12.3 CSL
12.3.1 CSL Corporation Information
12.3.2 CSL Description and Business Overview
12.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Intravenous Immunoglobulin (IVIg) Products Offered
12.3.5 CSL Recent Development
12.4 Octapharma
12.4.1 Octapharma Corporation Information
12.4.2 Octapharma Description and Business Overview
12.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered
12.4.5 Octapharma Recent Development
12.5 Biotest
12.5.1 Biotest Corporation Information
12.5.2 Biotest Description and Business Overview
12.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Biotest Intravenous Immunoglobulin (IVIg) Products Offered
12.5.5 Biotest Recent Development
12.6 Kedrion
12.6.1 Kedrion Corporation Information
12.6.2 Kedrion Description and Business Overview
12.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered
12.6.5 Kedrion Recent Development
12.7 Hualan Bio
12.7.1 Hualan Bio Corporation Information
12.7.2 Hualan Bio Description and Business Overview
12.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered
12.7.5 Hualan Bio Recent Development
12.8 CNBG
12.8.1 CNBG Corporation Information
12.8.2 CNBG Description and Business Overview
12.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CNBG Intravenous Immunoglobulin (IVIg) Products Offered
12.8.5 CNBG Recent Development
12.9 Shanghai RAAS
12.9.1 Shanghai RAAS Corporation Information
12.9.2 Shanghai RAAS Description and Business Overview
12.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered
12.9.5 Shanghai RAAS Recent Development
12.10 CBPO
12.10.1 CBPO Corporation Information
12.10.2 CBPO Description and Business Overview
12.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CBPO Intravenous Immunoglobulin (IVIg) Products Offered
12.10.5 CBPO Recent Development
12.11 Baxter
12.11.1 Baxter Corporation Information
12.11.2 Baxter Description and Business Overview
12.11.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Baxter Intravenous Immunoglobulin (IVIg) Products Offered
12.11.5 Baxter Recent Development
12.12 BPL
12.12.1 BPL Corporation Information
12.12.2 BPL Description and Business Overview
12.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 BPL Products Offered
12.12.5 BPL Recent Development
12.13 Sichuan Yuanda Shuyang
12.13.1 Sichuan Yuanda Shuyang Corporation Information
12.13.2 Sichuan Yuanda Shuyang Description and Business Overview
12.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sichuan Yuanda Shuyang Products Offered
12.13.5 Sichuan Yuanda Shuyang Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Intravenous Immunoglobulin (IVIg) Industry Trends
13.2 Intravenous Immunoglobulin (IVIg) Market Drivers
13.3 Intravenous Immunoglobulin (IVIg) Market Challenges
13.4 Intravenous Immunoglobulin (IVIg) Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intravenous Immunoglobulin (IVIg) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of IVIg Liquid
Table 3. Major Manufacturers of IVIg Powder
Table 4. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application (2021-2027) & (K Bottle)
Table 5. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (K Bottle) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales by Regions (2016-2021) & (K Bottle)
Table 7. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions (2016-2021)
Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2022-2027) & (K Bottle)
Table 10. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2021) (K Bottle)
Table 14. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Revenue (US$ Million) in 2020
Table 16. Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2016-2021)
Table 18. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2020)
Table 20. Key Manufacturers Intravenous Immunoglobulin (IVIg) Price (2016-2021) (USD/Bottle)
Table 21. Intravenous Immunoglobulin (IVIg) Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
Table 23. Date of International Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) (K Bottle)
Table 26. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2016-2021)
Table 27. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2016-2021)
Table 29. Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Type (2016-2021) & (USD/Bottle)
Table 30. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2022-2027) & (K Bottle)
Table 31. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Bottle)
Table 35. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) (K Bottle)
Table 36. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2016-2021)
Table 37. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2016-2021)
Table 39. Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Application (2016-2021) & (USD/Bottle)
Table 40. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2022-2027) & (K Bottle)
Table 41. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Bottle)
Table 45. China Intravenous Immunoglobulin (IVIg) Sales (K Bottle) of Key Companies (2016-2021)
Table 46. China Intravenous Immunoglobulin (IVIg) Sales Share by Company (2016-2021)
Table 47. China Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Company (2016-2021)
Table 48. China Intravenous Immunoglobulin (IVIg) Revenue Share by Company (2016-2021)
Table 49. China Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2016-2021)
Table 50. China Intravenous Immunoglobulin (IVIg) Sales Share by Type (2016-2021)
Table 51. China Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2016-2021)
Table 53. China Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2022-2027)
Table 54. China Intravenous Immunoglobulin (IVIg) Sales Share by Type (2022-2027)
Table 55. China Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2022-2027)
Table 57. China Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2022-2027)
Table 58. China Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2016-2021)
Table 59. China Intravenous Immunoglobulin (IVIg) Sales Share by Application (2016-2021)
Table 60. China Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2016-2021)
Table 62. China Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2022-2027)
Table 63. China Intravenous Immunoglobulin (IVIg) Sales Share by Application (2022-2027)
Table 64. China Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2022-2027)
Table 66. China Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2022-2027)
Table 67. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 68. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 69. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) & (K Bottle)
Table 72. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)
Table 75. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 76. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 77. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 79. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 80. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 84. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2016-2021)
Table 87. Baxter Corporation Information
Table 88. Baxter Description and Business Overview
Table 89. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 90. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 91. Baxter Recent Development
Table 92. Grifols Corporation Information
Table 93. Grifols Description and Business Overview
Table 94. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 95. Grifols Product
Table 96. Grifols Recent Development
Table 97. CSL Corporation Information
Table 98. CSL Description and Business Overview
Table 99. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 100. CSL Product
Table 101. CSL Recent Development
Table 102. Octapharma Corporation Information
Table 103. Octapharma Description and Business Overview
Table 104. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 105. Octapharma Product
Table 106. Octapharma Recent Development
Table 107. Biotest Corporation Information
Table 108. Biotest Description and Business Overview
Table 109. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 110. Biotest Product
Table 111. Biotest Recent Development
Table 112. Kedrion Corporation Information
Table 113. Kedrion Description and Business Overview
Table 114. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 115. Kedrion Product
Table 116. Kedrion Recent Development
Table 117. Hualan Bio Corporation Information
Table 118. Hualan Bio Description and Business Overview
Table 119. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 120. Hualan Bio Product
Table 121. Hualan Bio Recent Development
Table 122. CNBG Corporation Information
Table 123. CNBG Description and Business Overview
Table 124. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 125. CNBG Product
Table 126. CNBG Recent Development
Table 127. Shanghai RAAS Corporation Information
Table 128. Shanghai RAAS Description and Business Overview
Table 129. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 130. Shanghai RAAS Product
Table 131. Shanghai RAAS Recent Development
Table 132. CBPO Corporation Information
Table 133. CBPO Description and Business Overview
Table 134. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 135. CBPO Product
Table 136. CBPO Recent Development
Table 137. LFB Group Corporation Information
Table 138. LFB Group Description and Business Overview
Table 139. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 140. LFB Group Product
Table 141. LFB Group Recent Development
Table 142. BPL Corporation Information
Table 143. BPL Description and Business Overview
Table 144. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 145. BPL Product
Table 146. BPL Recent Development
Table 147. Sichuan Yuanda Shuyang Corporation Information
Table 148. Sichuan Yuanda Shuyang Description and Business Overview
Table 149. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 150. Sichuan Yuanda Shuyang Product
Table 151. Sichuan Yuanda Shuyang Recent Development
Table 152. Intravenous Immunoglobulin (IVIg) Market Trends
Table 153. Intravenous Immunoglobulin (IVIg) Market Drivers
Table 154. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 155. Intravenous Immunoglobulin (IVIg) Market Restraints
Table 156. Intravenous Immunoglobulin (IVIg) Customers List
Table 157. Intravenous Immunoglobulin (IVIg) Distributors List
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
Figure 2. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020 & 2027
Figure 3. IVIg Liquid Product Picture
Figure 4. IVIg Powder Product Picture
Figure 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020 & 2027
Figure 6. Immunodeficiency
Figure 7. Autoimmune Disease
Figure 8. Acute Infection
Figure 9. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 10. Global Intravenous Immunoglobulin (IVIg) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Intravenous Immunoglobulin (IVIg) Market Size 2016-2027 (US$ Million)
Figure 12. Global Intravenous Immunoglobulin (IVIg) Sales 2016-2027 (K Bottle)
Figure 13. Global Intravenous Immunoglobulin (IVIg) Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Figure 15. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2020
Figure 16. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)
Figure 17. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in 2020
Figure 18. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Intravenous Immunoglobulin (IVIg) Revenue in 2020
Figure 20. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2021)
Figure 22. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2020
Figure 23. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2021)
Figure 24. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type in 2020
Figure 25. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2021)
Figure 26. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020
Figure 27. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2016-2021)
Figure 28. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application in 2020
Figure 29. China Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2016-2027 (K Bottle)
Figure 30. China Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Intravenous Immunoglobulin (IVIg) Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue in Intravenous Immunoglobulin (IVIg) in 2020
Figure 33. China Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2016-2021)
Figure 34. China Intravenous Immunoglobulin (IVIg) Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2016-2021)
Figure 36. China Intravenous Immunoglobulin (IVIg) Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2016-2021 (K Bottle)
Figure 38. North America Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2020
Figure 40. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2020
Figure 41. U.S. Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2016-2021) (K Bottle)
Figure 42. U.S. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2016-2021) (K Bottle)
Figure 44. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Intravenous Immunoglobulin (IVIg) Sales Growth Rate 2016-2021 (K Bottle)
Figure 46. Europe Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2020
Figure 48. Europe Intravenous Immunoglobulin (IVIg) Revenue Market

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs